Industry updates from the field of stem cell research and regenerative medicine in February 2022-Reference-Cited by-同舟云学术

Industry updates from the field of stem cell research and regenerative medicine in February 2022

Published:2022-06 Issue:6 Volume:17 Page:327-336
ISSN:1746-0751
Container-title:Regenerative Medicine
language:en
Short-container-title:Regenerative Medicine

Author:

Ilic Dusko¹^ORCID,Liovic Mirjana²^ORCID

Affiliation:

1. Department of Women & Children’s Health, Stem Cell Laboratories, Guy’s Assisted Conception Unit, Faculty of Life Sciences & Medicine, King’s College London, London, SE1 9RT, UK

2. Medical Center for Molecular Biology, Faculty of Medicine, University of Ljubljana, Ljubljana, 1000, Slovenia

Abstract

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from non academic institutions in February 2022.

Publisher

Future Medicine Ltd

Subject

Embryology,Biomedical Engineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/rme-2022-0046

Reference45 articles.

1. BioNTec. BioNTech and Medigene announce global collaboration to advance T-cell receptor immunotherapies against cancer. (2022). https://investors.biontech.de/node/11721/pdf

2. Neukio Biotherapeutics. EdiGene and Neukio enter collaboration to develop next-generation immune cell therapies. (2022). www.neukio.com/en/neukio-news-40

3. Intellia Therapeutics. Intellia and ONK Therapeutics announce collaboration to advance allogeneic CRISPR-Edited NK cell therapies for the treatment of patients with cancer. (2022). https://ir.intelliatx.com/node/10041/pdf

4. Arbor Biotechnologies. EdiGene and Arbor Biotechnologies announce worldwide non-exclusive license agreement to advance ex vivo engineered cell therapy programs. (2022). https://static1.squarespace.com/static/5a9c785b70e80290e8ec1399/t/61f813b3ce78756a23b47880/1643647923437/220129+Press+Release_EdiGene+Arbor_FINAL.pdf

5. eQcell. Likarda and eQcell announce license option agreement. (2022). www.eqcell.com/_files/ugd/5814b5_1d08ff5877d544aebe2233a785e25cd3.pdf

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ready, set, regenerate! A retrospect of 2022;Regenerative Medicine;2023-01

2. Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes;International Journal of Molecular Sciences;2022-08-08